{"id":"https://openalex.org/W4287922012","doi":"https://doi.org/10.3389/fonc.2022.873570","title":"Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients \u2014A retrospective study","display_name":"Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients \u2014A retrospective study","publication_year":2022,"publication_date":"2022-07-26","ids":{"openalex":"https://openalex.org/W4287922012","doi":"https://doi.org/10.3389/fonc.2022.873570","pmid":"https://pubmed.ncbi.nlm.nih.gov/35957911","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9360505"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.873570","doi":"https://doi.org/10.3389/fonc.2022.873570","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.873570","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057134338","display_name":"Qiuyue Liu","orcid":"https://orcid.org/0000-0002-6643-1730","observed_orcids":["https://orcid.org/0000-0002-6643-1730"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiuyue Liu","raw_affiliation_strings":["Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103369582","display_name":"Juan Jan Qiu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099937","display_name":"Fourth People\u2019s Hospital of Jinan","ror":"https://ror.org/012xbj452","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210099937"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Juan Qiu","raw_affiliation_strings":["Oncology Department, The Fourth People's Hospital of Jinan, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, The Fourth People's Hospital of Jinan, Jinan, China","institution_ids":["https://openalex.org/I4210099937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075218387","display_name":"Qianrun Lu","orcid":"https://orcid.org/0000-0002-1974-7468","observed_orcids":["https://orcid.org/0000-0002-1974-7468"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qianrun Lu","raw_affiliation_strings":["Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101893734","display_name":"Yujin Ma","orcid":"https://orcid.org/0000-0003-2054-3398","observed_orcids":["https://orcid.org/0000-0003-2054-3398","https://orcid.org/0000-0003-3492-7229"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yujin Ma","raw_affiliation_strings":["Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shu Fang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shu Fang","raw_affiliation_strings":["Department of Breast Medicine, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medicine, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Bing Bu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bing Bu","raw_affiliation_strings":["Department of Breast Medicine, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medicine, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114500316","display_name":"Lihua Song","orcid":"https://orcid.org/0000-0003-2835-0099","observed_orcids":["https://orcid.org/0000-0003-2835-0099"]},"institutions":[{"id":"https://openalex.org/I4210100830","display_name":"Shandong Tumor Hospital","ror":"https://ror.org/01413r497","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210100830"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Lihua Song","raw_affiliation_strings":["Department of Breast Medicine, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Breast Medicine, Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Shandong First Medical University, Jinan, China","institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5114500316"],"corresponding_institution_ids":["https://openalex.org/I4210100830","https://openalex.org/I4210163399"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.5231,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.51903128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"12","issue":null,"first_page":"873570","last_page":"873570"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8935999870300293,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8935999870300293,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.10090000182390213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8799999952316284},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.8610000014305115},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9480000138282776},{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9259999990463257},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9850000143051147},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ki-67-proliferation-index","display_name":"Ki-67 proliferation index","score":0.925000011920929},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/smote-oversampling","display_name":"SMOTE oversampling","score":0.8299999833106995}],"concepts":[{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7506891489028931},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.742461085319519},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7202289700508118},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6310399770736694},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.582993745803833},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.5638970136642456},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4971487820148468},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46626362204551697},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45085424184799194},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.1466473937034607}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2022.873570","doi":"https://doi.org/10.3389/fonc.2022.873570","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.873570","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:35957911","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35957911","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9360505","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9360505/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:2a50ad20ac3d4eb88a3ff4fcc6d201c9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2a50ad20ac3d4eb88a3ff4fcc6d201c9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.873570","doi":"https://doi.org/10.3389/fonc.2022.873570","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.873570","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4287922012.pdf","grobid_xml":"https://content.openalex.org/works/W4287922012.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1803295013","https://openalex.org/W1966804628","https://openalex.org/W1968993577","https://openalex.org/W1979832413","https://openalex.org/W2029866800","https://openalex.org/W2044702943","https://openalex.org/W2057737812","https://openalex.org/W2074351294","https://openalex.org/W2081202499","https://openalex.org/W2112657305","https://openalex.org/W2131106781","https://openalex.org/W2158118614","https://openalex.org/W2162755162","https://openalex.org/W2164621703","https://openalex.org/W2204530481","https://openalex.org/W2290950904","https://openalex.org/W2328198526","https://openalex.org/W2404884142","https://openalex.org/W2537305086","https://openalex.org/W2552099557","https://openalex.org/W2560367415","https://openalex.org/W2560635244","https://openalex.org/W2570874981","https://openalex.org/W2606926876","https://openalex.org/W2620993107","https://openalex.org/W2760986981","https://openalex.org/W2763875663","https://openalex.org/W2796824128","https://openalex.org/W2800938829","https://openalex.org/W2896846857","https://openalex.org/W2913589615","https://openalex.org/W2948574507","https://openalex.org/W2967901922","https://openalex.org/W2988364315","https://openalex.org/W2995593755","https://openalex.org/W3010197652","https://openalex.org/W3014453916","https://openalex.org/W3083145960","https://openalex.org/W3120899641","https://openalex.org/W3128646645","https://openalex.org/W3165114271","https://openalex.org/W3197162231","https://openalex.org/W4211032970","https://openalex.org/W4240150780","https://openalex.org/W4301159569"],"related_works":["https://openalex.org/W2796824128","https://openalex.org/W2112276661","https://openalex.org/W4367174989","https://openalex.org/W3006217746","https://openalex.org/W2910346925","https://openalex.org/W3170288793","https://openalex.org/W2344659104","https://openalex.org/W3042644564","https://openalex.org/W1488713932","https://openalex.org/W2556970382"],"abstract_inverted_index":{"Purpose:":[0],"The":[1,39,78,247],"purpose":[2],"of":[3,19,86,101,124,162,190,226,349],"this":[4,43,290],"study":[5,44,129,291],"was":[6,155,285],"to":[7,60,115,119,292],"evaluate":[8],"endocrine":[9,149,153,186,194,230,257],"therapy":[10,154,196,207,232,249,327,337],"and":[11,16,27,34,37,82,96,138,147,164,179,210,214,280,331,346],"chemotherapy":[12,146,159,175],"for":[13,168,322,343],"first-line,":[14,344],"maintenance,":[15,345],"second-line":[17,347],"treatment":[18,32,89,275,278,282,320,348],"hormone":[20],"receptor-positive":[21],"HER-2-negative":[22],"metastatic":[23,49],"breast":[24,50],"cancer":[25,51],"(HR+HER-2-MBC)":[26],"the":[28,64,76,87,97,102,108,117,121,193,200,205,215,221,229,235,239,244,256,266,271,295,302,340],"relationship":[29],"between":[30],"different":[31],"options":[33],"survival.":[35,299],"Patients":[36],"methods:":[38],"patients":[40,66,70,132,136,140,172,183,272],"included":[41,74,130],"in":[42,75,104,160,220,243,265,289,301],"were":[45,73,91,142,261,324],"all":[46],"diagnosed":[47],"with":[48,67,71,133,144],"(MBC)":[52],"at":[53],"Shandong":[54],"Cancer":[55],"Hospital":[56],"from":[57],"January":[58],"2013":[59],"June":[61],"2017.":[62],"Of":[63],"951":[65],"MBC,":[68],"307":[69,131],"HR+HER-2-MBC":[72,323],"analysis.":[77],"progression-free":[79],"survival":[80,84],"(PFS)":[81],"overall":[83],"(OS)":[85],"various":[88],"modes":[90,321],"evaluated":[92],"using":[93],"Kaplan-Meier":[94],"analysis":[95],"log-rank":[98],"test.":[99],"Because":[100],"imbalance":[103],"data,":[105],"we":[106,307],"used":[107],"synthetic":[109],"minority":[110],"oversampling":[111],"technique":[112],"(SMOTE)":[113],"algorithm":[114],"oversample":[116],"data":[118],"increase":[120],"balanced":[122],"amount":[123],"data.":[125],"Results:":[126],"This":[127],"retrospective":[128],"HR+HER-2-MBC;":[134],"246":[135],"(80.13%)":[137],"61":[139],"(19.87%)":[141],"treated":[143],"first-line":[145,148,158,174,185,274],"therapy,":[150],"respectively.":[151],"First-line":[152],"better":[156,253,329],"than":[157,182,255,334],"terms":[161,189,225],"PFS":[163,178,330],"OS.":[165],"After":[166],"adjusting":[167],"known":[169],"prognostic":[170],"factors,":[171],"receiving":[173,184,273],"had":[176,314],"poorer":[177],"OS":[180,332],"outcomes":[181,333],"therapy.":[187],"In":[188,224],"maintenance":[191,197,208,212,277],"treatment,":[192,228],"therapy-endocrine":[195],"mode":[198,209,217,233,241,250],"achieved":[199,234,251,328],"best":[201,236],"prognosis,":[202,237],"followed":[203],"by":[204],"chemotherapy-endocrine":[206],"chemotherapy-chemotherapy":[211],"mode,":[213],"no-maintenance":[216],"has":[218],"resulted":[219,242],"worst":[222,245],"prognosis.":[223,246,317],"first-line/second-line":[227,281,303],"therapy/endocrine":[231],"while":[238],"chemotherapy/chemotherapy":[240],"chemotherapy/endocrine":[248],"a":[252,315],"prognosis":[254],"therapy/chemotherapy":[258],"mode.":[259],"There":[260,284],"no":[262,286],"significant":[263],"differences":[264],"KI-67":[267,296,311],"index":[268,297],"(<15%/15-30%/\u226530%)":[269],"among":[270],"modes,":[276,279],"modes.":[283],"statistical":[287],"evidence":[288],"support":[293],"that":[294,310],"affected":[298],"However,":[300],"model,":[304],"after":[305],"SMOTE,":[306],"could":[308],"see":[309],"\u2265":[312],"30%":[313],"poor":[316],"Conclusions:":[318],"Different":[319],"analyzed.":[325],"Endocrine":[326,336],"chemotherapy.":[335],"should":[338],"be":[339],"first":[341],"choice":[342],"HR+HER-2-MBC.":[350]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-07-26T00:00:00"}